Royal Bank of Canada’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,616
| Closed | -$2K | – | 7266 |
|
|
2020
Q2 | $2K | Sell |
2,616
-1,774
| -40% | -$1.5K | ﹤0.01% | 6364 |
|
|
2020
Q1 | $3K | Buy |
4,390
+4,222
| +2,513% | +$5.17K | ﹤0.01% | 6260 |
|
|
2019
Q4 | $0 | Sell |
168
-132
| -44% | -$369 | ﹤0.01% | 7405 |
|
|
2019
Q3 | $1K | Buy |
300
+220
| +275% | +$1.28K | ﹤0.01% | 6621 |
|
|
2019
Q2 | $1K | Sell |
80
-38
| -32% | -$259 | ﹤0.01% | 6803 |
|
|
2019
Q1 | $1K | Hold |
118
| – | – | ﹤0.01% | 6744 |
|
|
2018
Q4 | $1K | Sell |
118
-184
| -61% | -$2.05K | ﹤0.01% | 6672 |
|
|
2018
Q3 | $6K | Buy |
302
+147
| +95% | +$5.25K | ﹤0.01% | 6231 |
|
|
2018
Q2 | $9K | Buy |
155
+45
| +41% | +$2.28K | ﹤0.01% | 5879 |
|
|
2018
Q1 | $4K | Sell |
110
-49
| -31% | -$2.1K | ﹤0.01% | 6023 |
|
|
2017
Q4 | $8K | Sell |
159
-593
| -79% | -$31.3K | ﹤0.01% | 5961 |
|
|
2017
Q3 | $33K | Buy |
752
+702
| +1,404% | +$32K | ﹤0.01% | 5669 |
|
|
2017
Q2 | $2K | Sell |
50
-373
| -88% | -$22K | ﹤0.01% | 6339 |
|
|
2017
Q1 | $31K | Sell |
423
-275
| -39% | -$18.2K | ﹤0.01% | 5406 |
|
|
2016
Q4 | $41K | Buy |
698
+576
| +472% | +$52.8K | ﹤0.01% | 5378 |
|
|
2016
Q3 | $15K | Sell |
122
-125
| -51% | -$16K | ﹤0.01% | 5663 |
|
|
2016
Q2 | $31K | Sell |
247
-8
| -3% | -$920 | ﹤0.01% | 5323 |
|
|
2016
Q1 | $21K | Sell |
255
-620
| -71% | -$51.1K | ﹤0.01% | 5477 |
|
|
2015
Q4 | $86K | Sell |
875
-741
| -46% | -$79.4K | ﹤0.01% | 5021 |
|
|
2015
Q3 | $198K | Sell |
1,616
-324
| -17% | -$44K | ﹤0.01% | 4334 |
|
|
2015
Q2 | $298K | Buy |
+1,940
| New | +$320K | ﹤0.01% | 4055 |
|
|
2014
Q4 | – | Sell |
-1,952
| Closed | -$207K | – | 6394 |
|
|
2014
Q3 | $207K | Buy |
+1,952
| New | +$272K | ﹤0.01% | 4163 |
|
|
2014
Q1 | – | Sell |
-1,911
| Closed | -$333K | – | 6262 |
|
|
2013
Q4 | $333K | Buy |
1,911
+1,848
| +2,933% | +$318K | ﹤0.01% | 3735 |
|
|
2013
Q3 | $10K | Sell |
63
-2,390
| -97% | -$376K | ﹤0.01% | 5432 |
|
|
2013
Q2 | $326K | Buy |
+2,453
| New | +$346K | ﹤0.01% | 3513 |
|
Other funds holding ELGX
Royal Bank of Canada's ELGX Position: Q3 2020 in Review
Royal Bank of Canada sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 2,616 shares — an estimated $2K sold.
Royal Bank of Canada first reported a position in ELGX in Q2 2013 and held it in 25 quarters. The position peaked at $333K in Q4 2013. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- Royal Bank of Canada reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- Royal Bank of Canada sold 2,616 Endologix Inc shares in Q3 2020, an estimated $2K.
- Royal Bank of Canada first reported a position in Endologix Inc in Q2 2013 and held it in 25 quarters.
- Royal Bank of Canada's Endologix Inc position peaked at $333K in Q4 2013.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.